Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: The non-insulin requiring autoimmune diabetes (NIRAD) study 2

Diabetes

Volumn 57, Issue 5, 2008, Pages 1276-1283

  Tiberti, Claudio ^a   Giordano, Carla ^b   Locatelli, Mattia ^c   Bosi, Emanuele ^d   Bottazzo, Gian Franco ^c   Buzzetti, Raffaella ^a   Cucinotta, Domenico ^e   Galluzzo, Aldo ^b   Falorni, Alberto ^f   Dotta, Francesco ^g  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^e UNIVERSITY OF MESSINA   (Italy)

^f UNIVERSITY OF PERUGIA   (Italy)

^g UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPITOPE; GLUTAMATE DECARBOXYLASE ANTIBODY; PROTEIN TYROSINE PHOSPHATASE; TYROSINE PHOSPHATASE 2; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; PEPTIDE FRAGMENT;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CAUCASIAN; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; GENOTYPE; HIGH RISK POPULATION; HLA SYSTEM; HUMAN; HUMORAL IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RADIOIMMUNOASSAY; RISK FACTOR; BLOOD; CHEMISTRY; CLINICAL TRIAL; HEALTH SURVEY; IMMUNOLOGY; ITALY; MULTICENTER STUDY; PANCREAS ISLET;

ADULT; AUTOANTIBODIES; AUTOIMMUNITY; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; HEALTH SURVEYS; HUMANS; ISLETS OF LANGERHANS; ITALY; PEPTIDE FRAGMENTS; PROTEIN TYROSINE PHOSPHATASES;

EID: 48449102338     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-0874     Document Type: Article

References (41)

1. Atkinson MA, Eisenbarth GS: Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221-229, 2001
2. Vandewalle CL, Falorni A, Svanholm S, Lernmark A, Pipeleers DG, Gorus FK: High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. J Clin Endocrinol Metab 80:846-851, 1995
3. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR: Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with non-insulin-dependent onset of diabetes. Diabetes: 42:359-362, 1993
4. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R, UK Prospective Diabetes Study Group: UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet 350:1288-1293, 1997
5. Fourlanos S, Dotta F, Greenbaum CJ, Palmer JP, Rolandsson O, Colman PG, Harrison C: Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 48:1960-1967, 2005
6. Kobayashi T, Tamemoto Nakanishi K, Kato N, Okubo M, Kajio H, Sugimoto T, Murase T, Kosaka K: Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 16:780-788, 1993
7. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang DA: Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to Glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11:299-303, 1994
8. Juneja R, Palmer JP: Type 1 1/2 diabetes: myth or reality? Autoimmunity 29:65-83, 1999
9. Pozzilli P, Di Mario U: Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention. Diabetes Care 24:1460-1467, 2001
10. Falorni A, Gambelunghe G:, Forini F, Kassi G, Cosentino A, Candeloro P, Bolli GB, Brunetti P, Calcinaro F: Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus. J Clin Endocrinol Metab 85:309-316, 2000
11. Maioli M, Alejandro E, Tonolo G, Gilliam LK, Bekris L, Hampe CS, Obinu DA, Manconi A, Puddu L, Lynch K, Lernmark A: Epitope-restricted 65-kilodalton glutamic acid autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes. J Clin Endocrinol Metab 89: 5675-5682
12. Kobayashi T, Tanaka S, Okubo M, Nakanishi K, Murase T, Lernmark A: Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes. J Clin Endocrinol Metab 88:4768-4775, 2003
13. Bottazzo GF, Bosi E, Cull CA, Bonifacio E, Locatelli M, Zimmet P, Mackay IR, Holman RR: IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71). Diabetologia 48:703-708, 2005
14. Verge CF, Stenger D, Bonifacio E, Colman PG, Pilcher C, Bingley BJ, Eisenbarth GS: Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: combinatorial islet autoantibody workshop. Diabetes 47:1857-1866, 1998
15. Bingley PJ, Bonifacio E, Mueller P, participating laboratories: Diabetes antibody standardization program: first assay proficiency evaluation. Diabetes 52:1128-1136, 2003
16. Tiberti C, Verrienti A, Fiore B, Yu L, Eisenbarth GS, Dotta F, Di Mario U: IA-2 combined epitope assay: a new, highly sensitive approach to evaluate IA-2 humoral autoimmunity in type 1 diabetes. Clin Immunol 115:260-267, 2005
17. Kawasaki E, Sera Y, Fujita N, Yamauchi M, Ozaki M, Abe T, Yamakawa K, Uotani S, Takino H, Yamasaki H, Yamaguchi Y, Uchigata Y, Matsuura N, Eguchi K: Association between IA-2 autoantibody epitope specificities and age of onset in Japanese patients with autoimmune diabetes. J Autoimmun 17:323-331, 2001
18. Buzzetti R, Di Pietro S, Giaccari A, Petrone A, Locatelli M, Suraci C, Capizzi M, Arpi ML, Dotta F, Bosi E, for the NIRAD Study Group: High titre of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Diabetes Care 30:932-938, 2007
19. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 29:S43-S48, 2006
20. Park YS, Kawasaki E, Kelemen K, Yu L, Schiller MR, Rewers M, Minuta M, Eisenbarth GS, Hutton JC: Humoral autoreactivity to an alternatively spliced variant of ICA512/IA-2 in type 1 diabetes. Diabetologia 43:1293-1301, 2000
21. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L, Karlsen AE, Boel E, Michelsen B, Lernmark A: A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37: 344-350
22. Erlich H, Bugawan T, Begovich AB, Scharf S, Griffith R, Saiki R, Higuchi R, Walsh PS: HLA-DR, DQ and DP typing using PCR amplification and immobilized probes. Eur J Immunogenet 18:33-55, 1991
23. Buzzetti R, Galgani A, Petrone A, Del Buono ML, Erlich HA, Bugawan TL, Lorini R, Meschi F, Multari G, Pozzilli P, Locatelli M, Bottazzo G, Di Mario U: Genetic prediction of type 1 diabetes in a population with low frequency of HLA risk genotypes and low incidence of the disease (the DIABFIN Study). Metab Res Rev 20:137-143, 2004
24. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E: Identification of protein tyrosine phosphatase-like (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J Immunol 155:5419-5426, 1995
25. Lan MS, Wasserfall C, Maclaren NK, Notkins AL: IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad S USA 93:6367-6370, 1996
26. Bingley BJ, Bonifacio E, Williams AJK, Genovese S, Bottazzo GF, Gale EAM: Prediction of IDDM in the general population: strategies based on combination of autoantibody markers. Diabetes 46:1701-1710, 1997
27. Hawa M, Rowe R, Lan MS, Notkins AL, Pozzilli P, Christie MR, Leslie RDG: Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes. Diabetes 46:1270-1275, 1997
28. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS: Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933, 1996
29. Ellis TM, Schatz DA, Ottendorfer EW, Lan MS, Wasserfall C, Salisbury PJ, She JX, Notkins AL, Maclaren NK, Atkinson MA: The relationship between humoral and cellular immunity to IA-2 in IDDM. Diabetes 47:566-569,1998
30. Dotta F, Dionisi S, Viglietta V, Tiberti C, Matteoli MC, Cervoni M, Bizzarri C, Marietti G, Testi M, Multari G, Lucentini L, Di Mario U: T-cell mediated autoimmunity to the IA-2 islet tyrosine phosphatase in type 1 diabetes mellitus. Eur J Endocrinol 141:272-278, 1999
31. Lampasona V, Bearzatto M, Genovese S, Bosi E, Ferrari M, Bonifacio E: Autoantibodies in insulin-dependent diabetes recognize distinct cytoplas-mic domains of the protein tyrosine phosphatase-like IA-2 autoantigen. J Immunol 157:2707-2711, 1995
32. Zhang B, Lan MS, Notkins AL: Autoantibodies to IA-2 in IDDM. Diabetes 46:40-43, 1997
33. Kawasaki E, Yu L, Rewers MJ, Hutton JC, Eisenbarth GS: Definition of multiple ICA/512 phogrin autoantibody epitopes and detection of intermo-lecular epitope spreading in relatives of patients with type 1 diabetes. Diabetes 47:733-742, 1998
34. Naserke HN, Ziegler AG, Lampasona V, Bonifacio E: Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes. J Immunol 161:6963-6969, 1998
35. Seissler M, Schlott N, Morgenthaler G, Sherbaum WA: Mapping of novel autoreactive epitopes of the diabetes-associated autoantigen IA-2. Clin Exp Immunol 122:157-163, 2000
36. Kolm-Litty V, Berlo S, Bonifacio E, Bearzatto M, Engel AM, Christie M, Ziegler AG, Wilde T, Endl J: Human monoclonal antibodies isolated from type 1 diabetes patients define multiple epitopes in the protein tyrosine phosphatase-like IA-2 antigen. J Immunol 165:4676-4684, 2000
37. Falorni A, Brozzetti A: 2005 Diabetes-related antibodies in adult diabetic patients. Best Pract Res Clin Endocrinol Metab 19:119-133, 2005
38. Gambelunghe G, Forini F, Laureti S, Murdolo G, Toraldo G, Santeusanio F, Brunetti P, Sanjeevi CB, Falorni A: Increased risk for endocrine autoim-munity in Italian type 2 diabetic patients with GAD65 autoantibodies. Clin Endocrinol 52:565-573, 2000
39. Palmer JP, Hampe CS, Chiu H, Goel A, Brooks-Worrell BM: Is latent autoimmune diabetes in adults distinct from type 1 diabetes or just type 1 diabetes at an older age? Diabetes 54:S62-S67, 2005
40. Goel A, Chiu H, Felton J, Palmer JP, Brooks-Worrell B: T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe β-cell lesions in phenotypic type 2 diabetes. Diabetes 56:2110-2115, 2007
41. Di Lorenzo TP, Peakman M, Roep BO: Translational mini-review series on type 1 diabetes: systematic analysis of T cell epitopes in autoimmune diabetes. Clin Exp Immunol 148:1-16, 2007